Growth Opportunity Target expansion opportunities tied to Endotronix Cordella PA Sensor and remote heart failure management solutions, leveraging Edwards Lifesciences’ global footprint to accelerate adoption in 100+ countries and inpatient/outpatient care settings.

Acquisition Context Position with Edwards Lifesciences following the Endotronix acquisition news as a potential cross-sell or integration play for digital health and remote monitoring capabilities, aligning with Edwards’ structural heart leadership.

Digital Health Upsell Highlight potential sales for Endotronix Care Management Solution and remote monitoring software services to complement Edwards’ implantable devices, enhancing patient management post-implant and in NYHA class III populations.

Regulatory & PMA Momentum Capitalize on FDA PMA status for Cordella PA Sensor and anticipated U.S. launches to discuss bundled offerings, support services, and data analytics that integrate with Edwards’ clinical workflows and regulatory teams.

Strategic Partnerships Leverage existing and emerging partnerships with clinicians and healthcare stakeholders to propose joint go-to-market plays, training programs, and evidence generation collaborations that strengthen competitive positioning against peers.